Safinamide in Parkinson's Disease: A retrospective study

被引：0
|
作者：
Carmona-Abellan, M.
Erburu, M.
Cabrera, A.
Garcia-Monco, C.
Berganzo, K.
Huete, B.
机构：
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1378
引用
收藏
页码：S603 / S604
页数：2
相关论文
共 50 条
  • [21] Impact of SAfinamide on Depressive Symptoms in Parkinson's Disease Patients (SADness-PD Study): A Multicenter Retrospective Study
    Pena, Esteban
    Borrue, Carmen
    Mata, Marina
    Carlos Martinez-Castrillo, Juan
    Alonso-Canovas, Araceli
    Luis Chico, Juan
    Lopez-Manzanares, Lydia
    Llanero, Marcos
    Herreros-Rodriguez, Jaime
    Esquivel, Alberto
    Maycas-Cepeda, Teresa
    Ruiz-Huete, Cristina
    BRAIN SCIENCES, 2021, 11 (02) : 1 - 11
  • [22] Effects of safinamide in patients with Parkinson's disease measured by Parkinson's KinetiGraphTM
    Suttrup, I.
    Zentsch, V.
    Schroeder, J.
    Warnecke, T.
    MOVEMENT DISORDERS, 2016, 31 : S623 - S623
  • [23] The resurgence of neurotransmitter modulation in Parkinson's disease with safinamide
    Mueller, Thomas
    JOURNAL OF PARKINSONISM AND RESTLESS LEGS SYNDROME, 2015, 5 : 11 - 17
  • [24] Addition of Opicapone to Safinamide in Parkinson's Disease patients
    Russo, M.
    Carrarini, C.
    Dono, F.
    Di Pietro, M.
    Rispoli, M.
    Ferri, L.
    Onofrj, M.
    MOVEMENT DISORDERS, 2019, 34 : S80 - S80
  • [25] SURINPARK: Safinamide for Urinary Symptoms in Parkinson's Disease
    Gomez-Lopez, Ana
    Sanchez-Sanchez, Arantxa
    Natera-Villalba, Elena
    Ros-Castello, Victoria
    Beltran-Corbellini, Alvaro
    Fanjul-Arbos, Samira
    Parees Moreno, Isabel
    Lopez-Sendon Moreno, Jose Luis
    Martinez Castrillo, Juan Carlos
    Alonso-Canovas, Araceli
    BRAIN SCIENCES, 2021, 11 (01) : 1 - 8
  • [26] Effects of safinamide on pain in Parkinson's disease with motor fluctuations: an exploratory study
    Geroin, Christian
    Di Vico, Ilaria A.
    Squintani, Giovanna
    Segatti, Alessia
    Bovi, Tommaso
    Tinazzi, Michele
    JOURNAL OF NEURAL TRANSMISSION, 2020, 127 (08) : 1143 - 1152
  • [27] Anti-glutamatergic effect of safinamide in Parkinson's Disease: A TMS study
    Guerra, A.
    Suppa, A.
    D'Onofrio, V.
    Di Stasio, F.
    Asci, F.
    Fabbrini, G.
    Berardelli, A.
    MOVEMENT DISORDERS, 2018, 33 : S709 - S709
  • [28] Effects of safinamide on pain in Parkinson’s disease with motor fluctuations: an exploratory study
    Christian Geroin
    Ilaria A. Di Vico
    Giovanna Squintani
    Alessia Segatti
    Tommaso Bovi
    Michele Tinazzi
    Journal of Neural Transmission, 2020, 127 : 1143 - 1152
  • [29] Safinamide for pain management in patients with Parkinson's disease
    Abilashimova, D.
    Aubakirova, M.
    Abdildin, Y.
    Viderman, D.
    REVUE NEUROLOGIQUE, 2025, 181 (1-2) : 11 - 20
  • [30] SURINPARK: Safinamide for urinary symptoms in Parkinson's disease
    Gomez, A.
    Beltran Corbellini, A.
    Natera Villalba, E.
    Sanchez Sanchez, A.
    Perez Torre, P.
    Fanjul Arbos, S.
    Lopez Sendon-Moreno, J. L.
    Martinez Castrillo, J. C.
    Parees, I.
    Alonso Canovas, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 470 - 470
12345